Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study

This study evaluated whether secukinumab treatment for patients with moderate to severe plaque psoriasis correlates with improvements in symptoms of anxiety and depression. SUPREME was a 24-week, phase IIIb, multicentre, prospective study conducted across 50 centres in Italy with an extension period...

Descripción completa

Detalles Bibliográficos
Autores principales: TALAMONTI, Marina, MALARA, Giovanna, NATALINI, Ylenia, BARDAZZI, Federico, CONTI, Andrea, CHIRICOZZI, Andrea, MUGHEDDU, Cristina, GISONDI, Paolo, PIASERICO, Stefano, PAGNANELLI, Gianluca, AMERIO, Paolo, POTENZA, Concetta, CANTORESI, Franca, FARGNOLI, Maria Concetta, BALATO, Anna, LOCONSOLE, Francesco, OFFIDANI, Annamaria, BONIFATI, Claudio, PRIGNANO, Francesca, BARTEZAGHI, Marta, RAUSA, Alice, ALOISI, Elisabetta, ORSENIGO, Roberto, COSTANZO, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Publication of Acta Dermato-Venereologica 2021
Materias:
Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366680/
https://www.ncbi.nlm.nih.gov/pubmed/33269404
http://dx.doi.org/10.2340/00015555-3712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366680/
https://www.ncbi.nlm.nih.gov/pubmed/33269404
http://dx.doi.org/10.2340/00015555-3712

Ejemplares similares